Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2020

View Archived Issues

MTX-COVAB shows potent therapeutic and prophylactic activity in mode of advanced COVID-19

Enrollment ongoing in phase I study of BAY-1211163 in ARDS

Precision BioSciences reports interim phase I/II data on PBCAR-0191

AstraZeneca initiates first-in-human phase I study of AZD-3427

Lilly and UnitedHealth collaborate on pragmatic study of bamlanivimab for COVID-19

Interim analysis supports continuation of phase II/III GAIN trial of atuzaginstat in AD

CC Biotech describes new polypeptides for treating bacterial infections

New MAPK 1 inhibitors identified at Medshine Discovery

Ascentawits Pharmaceuticals discovers AKR1C3-activatable DNA alkylating drugs

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent RET inhibitors

New IDO-1 inhibitors synthesized at Hutchison MediPharma

mRNA SARS-CoV-2 vaccines to usher in 'golden age of vaccinology'

Kinase inhibitor for hearing loss protection

Data from phase II studies of VAL-083 in glioblastoma

FDA approves Saxenda to treat obesity in adolescents

Preliminary activity seen with ianalumab plus ibrutinib in relapsed/refractory CLL

Phase III study of maribavir to treat transplant recipients for CMV infection meets primary endpoint

FDA approves IND for Alligator's mitazalimab

Early phase I results show AVID-200 is well tolerated in myelofibrosis patients

HOOKIPA reports interim phase I data on HB-201 for HPV16+ cancers

New vulnerability in "KL" KRAS subtype

DoD grant to support evaluation of BXCL-501 for PTSD

FDA places clinical hold on phase I/II study of BPX-601

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...